
ASN Kidney Translation Series: Cardiovascular-Kidney-Metabolic (CKM) Syndrome Advances
0:00
1:06:22
ASN Kidney Translation explores advances in Cardiovascular-Kidney-Metabolic syndrome, including building a cardio-nephrology service (Kidney360), cardiorenal benefits of SGLT2 inhibitors & GLP-1 receptor agonists (JASN), & PREVENT risk prediction (CJASN).
Weitere Episoden von „Journal of the American Society of Nephrology (JASN)“



Verpasse keine Episode von “Journal of the American Society of Nephrology (JASN)” und abonniere ihn in der kostenlosen GetPodcast App.








